A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

PHASE1CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

September 30, 2012

Conditions
Rosacea
Interventions
DRUG

Metronidazole Topical Gel 1%

Metronidazole Topical Gel 1% applied to affected area once a day for 70 days

DRUG

Metronidazole Topical Gel 1% (Metrogel)

Metronidazole Topical Gel 1% applied to affected area once a day for 70 days

DRUG

Placebo

Placebo applied to affected area once a day for 70 days

Trial Locations (22)

Unknown

Investigator Site, Phoenix

Investigator Site, Long Beach

Investigator Site, Newport Beach

Investigator Site, Denver

Investigator Site, Jacksonville

Investigator Site, Miami

Investigator Site, Miramar

Investigator Site, Arlington Heights

Investigator Site, Plainfield

Investigator Site, Henderson

Investigator Site, Hickory

Investigator Site, High Point

Investigator Site, Wilmington

Investigator Site, South Euclid

Investigator Site, Hazleton

Investigator Site, Simpsonville

Investigator Site, Kingsport

Investigator Site, Knoxville

Investigator Site, Nashville

Investigator Site, San Antonio

Investigator Site, Webster

Investigator Site, West Jordan

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT01513863 - A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea | Biotech Hunter | Biotech Hunter